Specifically, CD8+ T cells serve as effector cells engaged in eradication of tumor cells through recognition of tumor-associated antigens and neoantigens presented by MHC class I. Simultaneously, CD4+ T cells provide support to CD8+ T cells by secreting a diverse range of effector cytokines. This evidence concerns the gene CD8A and neoplasm.